Aenova Appoints Hanno Scheffczik as Managing Director of its Marburg Site

Hanno Scheffczik has been appointed as the new Managing Director of Temmler Pharma, a member of the Aenova Group. Effective Mar. 1, 2023, he succeeds Alfred Veit, who is retiring.

With around 150 employees, the Aenova site in Marburg manufactures delayed-release tablets and capsules as well as moisture-sensitive dosage forms.

Scheffczik studied chemistry with a focus on biochemistry and earned his doctorate at the Institute of Virology at Philipps University in Marburg. After holding various development and management positions at international research-based pharmaceutical companies, he joined Aenova in 2021, initially as Head of Manufacturing Science & Technology.

"With Dr. Scheffczik we have a long-standing experienced manager and expert who knows the industry and Aenova very well," commented Jan Kengelbach, CEO of Aenova.

Hanno Scheffczik, Managing Director, Temmler Pharma (a member of the Aenova...
Hanno Scheffczik, Managing Director, Temmler Pharma (a member of the Aenova Group). Source: Aenova Group

Company

Logo:

Aenova Holding GmbH

Berger Strasse 8-10
82319 Starnberg
Germany

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read